The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 23, Issue 9, Pages e406-e415
Publisher
Elsevier BV
Online
2022-08-31
DOI
10.1016/s1470-2045(22)00221-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Concentration‐QT modelling in early clinical oncology settings: Simulation evaluation of performance
- (2021) Gael Cantet et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
- (2021) Daniela Baracaldo-Santamaría et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects
- (2021) Richat Abbas et al. Clinical Pharmacology in Drug Development
- Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies
- (2021) Mengfei Cheng et al. Frontiers in Cardiovascular Medicine
- Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice
- (2020) Florine A. Berger et al. BMC Medical Informatics and Decision Making
- Antiemetics: ASCO Guideline Update
- (2020) Paul J. Hesketh et al. JOURNAL OF CLINICAL ONCOLOGY
- QT Assessment in Early Drug Development: The Long and the Short of It
- (2019) Robert M. Lester et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A current understanding of drug-induced QT prolongation and its implications for anticancer therapy
- (2019) Dan M Roden CARDIOVASCULAR RESEARCH
- Measurement and Management of QT Interval Prolongation for General Physicians
- (2019) Praveen Indraratna et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Virtual Thorough QT (TQT) Trial—Extrapolation of In Vitro Cardiac Safety Data to In Vivo Situation Using Multi-Scale Physiologically Based Ventricular Cell-wall Model Exemplified with Tolterodine and Fesoterodine
- (2018) Nikunjkumar Patel et al. AAPS Journal
- QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update
- (2018) Scott R. Beach et al. PSYCHOSOMATICS
- Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives
- (2018) Jialin Duan et al. Oncotarget
- 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
- (2018) Sana M. Al-Khatib et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs
- (2018) Anita N. Bindraban et al. International Journal of Clinical Pharmacy
- Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
- (2017) Andreu Porta‐Sánchez et al. Journal of the American Heart Association
- Prevention and Treatment of Cancer-Related Infections
- (2017) Journal of the National Comprehensive Cancer Network
- 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
- (2016) F. Roila et al. ANNALS OF ONCOLOGY
- Predicting drug-induced QT prolongation and torsades de pointes
- (2016) Dan M. Roden JOURNAL OF PHYSIOLOGY-LONDON
- Predicting the Unpredictable
- (2016) Peter J. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk factors for QTc-prolongation: systematic review of the evidence
- (2016) Eline Vandael et al. International Journal of Clinical Pharmacy
- Which QT Correction Formulae to Use for QT Monitoring?
- (2016) Bert Vandenberk et al. Journal of the American Heart Association
- Effect of axitinib on the QT interval in healthy volunteers
- (2015) Ana Ruiz-Garcia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Corrected QT in Ventricular Paced Rhythms: What Is the Validation for Commonly Practiced Assumptions?
- (2015) Saneka Chakravarty et al. CARDIOLOGY
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
- (2015) Silvia G. Priori et al. EUROPEAN HEART JOURNAL
- Clinical and Genetic Determinants of Torsade de Pointes Risk
- (2012) Andrew J. Sauer et al. CIRCULATION
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
- (2011) Alison G. Freifeld et al. CLINICAL INFECTIOUS DISEASES
- Drug-induced hERG Block and Long QT Syndrome
- (2010) Harry J. Witchel Cardiovascular Therapeutics
- Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development
- (2009) Vaibhav Salvi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Accurate electrocardiographic assessment of the QT interval: Teach the tangent
- (2008) Pieter G. Postema et al. HEART RHYTHM
- Citalopram induced torsade de pointes, a rare life threatening side effect
- (2007) Somsupha Kanjanauthai et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now